APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Insulin Glulisine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Recombinant Insulin Glulisine Industry Growth and Trends Forecast to 2032

23 December 202570 pages

Choose your research edition.

Industry ResearchRecombinant Insulin Glulisine Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Insulin Glulisine Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Recombinant Insulin Glulisine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Insulin Glulisine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Insulin Glulisine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Recombinant Insulin Glulisine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Recombinant Insulin Glulisine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Recombinant Insulin Glulisine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Insulin Glulisine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Recombinant Insulin Glulisine include Sanofi, KALBE PHARMA and Amicus, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Recombinant Insulin Glulisine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Recombinant Insulin Glulisine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Recombinant Insulin Glulisine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Recombinant Insulin Glulisine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Recombinant Insulin Glulisine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Recombinant Insulin Glulisine Market by Company

Sanofi

KALBE PHARMA

Amicus

Recombinant Insulin Glulisine Segment by Type

Vial

Pre-filled

Recombinant Insulin Glulisine Segment by Application

Type 1 Diabetes

Type 2 Diabetes

Recombinant Insulin Glulisine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Insulin Glulisine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Insulin Glulisine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Insulin Glulisine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Recombinant Insulin Glulisine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Recombinant Insulin Glulisine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Vial Table 2. Major Company of Pre-filled Table 3. Global Recombinant Insulin Glulisine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Recombinant Insulin Glulisine Sales by Type (2021-2026) & (k units) Table 5. Global Recombinant Insulin Glulisine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Recombinant Insulin Glulisine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Recombinant Insulin Glulisine Sales Market Share in Value by Type (2021-2026) Table 8. Global Recombinant Insulin Glulisine Price by Type (2021-2026) & (USD/unit) Table 9. Global Recombinant Insulin Glulisine Sales by Type (2027-2032) & (k units) Table 10. Global Recombinant Insulin Glulisine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Recombinant Insulin Glulisine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Recombinant Insulin Glulisine Sales Market Share in Value by Type (2027-2032) Table 13. Global Recombinant Insulin Glulisine Price by Type (2027-2032) & (USD/unit) Table 14. North America Recombinant Insulin Glulisine Sales by Type (2021-2026) & (k units) Table 15. North America Recombinant Insulin Glulisine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Recombinant Insulin Glulisine Sales by Type (2021-2026) & (k units) Table 17. Europe Recombinant Insulin Glulisine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Recombinant Insulin Glulisine Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Recombinant Insulin Glulisine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Recombinant Insulin Glulisine Sales by Type (2021-2026) & (k units) Table 21. Latin America Recombinant Insulin Glulisine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Recombinant Insulin Glulisine Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Recombinant Insulin Glulisine Sales by Type (2021-2026) & (US$ Million) Table 24. Recombinant Insulin Glulisine Industry Trends Table 25. Recombinant Insulin Glulisine Industry Drivers Table 26. Recombinant Insulin Glulisine Industry Opportunities and Challenges Table 27. Recombinant Insulin Glulisine Industry Restraints Table 28. Global Recombinant Insulin Glulisine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Recombinant Insulin Glulisine Revenue Market Share by Company (2021-2026) Table 30. Global Recombinant Insulin Glulisine Sales by Company (2021-2026) & (k units) Table 31. Global Recombinant Insulin Glulisine Sales Share by Company (2021-2026) Table 32. Global Recombinant Insulin Glulisine Market Price by Company (2021-2026) & (USD/unit) Table 33. Global Recombinant Insulin Glulisine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Recombinant Insulin Glulisine Major Company Production Sites and Headquarters Table 35. Global Recombinant Insulin Glulisine Company, Product Type & Application Table 36. Global Recombinant Insulin Glulisine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Recombinant Insulin Glulisine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Recombinant Insulin Glulisine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Recombinant Insulin Glulisine Sales by Region (2021-2026) & (k units) Table 41. Global Recombinant Insulin Glulisine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Recombinant Insulin Glulisine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Recombinant Insulin Glulisine Sales Market Share in Value by Region (2021-2026) Table 44. Global Recombinant Insulin Glulisine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 45. Global Recombinant Insulin Glulisine Sales by Region (2027-2032) & (k units) Table 46. Global Recombinant Insulin Glulisine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Recombinant Insulin Glulisine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Recombinant Insulin Glulisine Sales Market Share in Value by Region (2027-2032) Table 49. Global Recombinant Insulin Glulisine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 50. Global Recombinant Insulin Glulisine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Recombinant Insulin Glulisine Sales by Application (2021-2026) & (k units) Table 52. Global Recombinant Insulin Glulisine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Recombinant Insulin Glulisine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Recombinant Insulin Glulisine Sales Market Share in Value by Application (2021-2026) Table 55. Global Recombinant Insulin Glulisine Price by Application (2021-2026) & (USD/unit) Table 56. Global Recombinant Insulin Glulisine Sales by Application (2027-2032) & (k units) Table 57. Global Recombinant Insulin Glulisine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Recombinant Insulin Glulisine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Recombinant Insulin Glulisine Sales Market Share in Value by Application (2027-2032) Table 60. Global Recombinant Insulin Glulisine Price by Application (2027-2032) & (USD/unit) Table 61. North America Recombinant Insulin Glulisine Sales by Application (2021-2026) & (k units) Table 62. North America Recombinant Insulin Glulisine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Recombinant Insulin Glulisine Sales by Application (2021-2026) & (k units) Table 64. Europe Recombinant Insulin Glulisine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Recombinant Insulin Glulisine Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Recombinant Insulin Glulisine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Recombinant Insulin Glulisine Sales by Application (2021-2026) & (k units) Table 68. Latin America Recombinant Insulin Glulisine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Recombinant Insulin Glulisine Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Recombinant Insulin Glulisine Sales by Application (2021-2026) & (US$ Million) Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi Recombinant Insulin Glulisine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Sanofi Recombinant Insulin Glulisine Product Portfolio Table 75. Sanofi Recent Development Table 76. KALBE PHARMA Company Information Table 77. KALBE PHARMA Business Overview Table 78. KALBE PHARMA Recombinant Insulin Glulisine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. KALBE PHARMA Recombinant Insulin Glulisine Product Portfolio Table 80. KALBE PHARMA Recent Development Table 81. Amicus Company Information Table 82. Amicus Business Overview Table 83. Amicus Recombinant Insulin Glulisine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Amicus Recombinant Insulin Glulisine Product Portfolio Table 85. Amicus Recent Development Table 86. North America Recombinant Insulin Glulisine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 87. North America Recombinant Insulin Glulisine Sales by Country (2021-2026) & (k units) Table 88. North America Recombinant Insulin Glulisine Sales Market Share by Country (2021-2026) Table 89. North America Recombinant Insulin Glulisine Sales Forecast by Country (2027-2032) & (k units) Table 90. North America Recombinant Insulin Glulisine Sales Market Share Forecast by Country (2027-2032) Table 91. North America Recombinant Insulin Glulisine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America Recombinant Insulin Glulisine Market Size by Country (2021-2026) & (US$ Million) Table 93. North America Recombinant Insulin Glulisine Market Share by Country (2021-2026) Table 94. North America Recombinant Insulin Glulisine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America Recombinant Insulin Glulisine Market Share Forecast by Country (2027-2032) Table 96. Europe Recombinant Insulin Glulisine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 97. Europe Recombinant Insulin Glulisine Sales by Country (2021-2026) & (k units) Table 98. Europe Recombinant Insulin Glulisine Sales Market Share by Country (2021-2026) Table 99. Europe Recombinant Insulin Glulisine Sales Forecast by Country (2027-2032) & (k units) Table 100. Europe Recombinant Insulin Glulisine Sales Market Share Forecast by Country (2027-2032) Table 101. Europe Recombinant Insulin Glulisine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe Recombinant Insulin Glulisine Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe Recombinant Insulin Glulisine Market Share by Country (2021-2026) Table 104. Europe Recombinant Insulin Glulisine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe Recombinant Insulin Glulisine Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Recombinant Insulin Glulisine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Recombinant Insulin Glulisine Sales by Country (2021-2026) & (k units) Table 108. Asia-Pacific Recombinant Insulin Glulisine Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific Recombinant Insulin Glulisine Sales Forecast by Country (2027-2032) & (k units) Table 110. Asia-Pacific Recombinant Insulin Glulisine Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Recombinant Insulin Glulisine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Recombinant Insulin Glulisine Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific Recombinant Insulin Glulisine Market Share by Country (2021-2026) Table 114. Asia-Pacific Recombinant Insulin Glulisine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific Recombinant Insulin Glulisine Market Share Forecast by Country (2027-2032) Table 116. Latin America Recombinant Insulin Glulisine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Latin America Recombinant Insulin Glulisine Sales by Country (2021-2026) & (k units) Table 118. Latin America Recombinant Insulin Glulisine Sales Market Share by Country (2021-2026) Table 119. Latin America Recombinant Insulin Glulisine Sales Forecast by Country (2027-2032) & (k units) Table 120. Latin America Recombinant Insulin Glulisine Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America Recombinant Insulin Glulisine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America Recombinant Insulin Glulisine Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America Recombinant Insulin Glulisine Market Share by Country (2021-2026) Table 124. Latin America Recombinant Insulin Glulisine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America Recombinant Insulin Glulisine Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Recombinant Insulin Glulisine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Recombinant Insulin Glulisine Sales by Country (2021-2026) & (k units) Table 128. Middle East and Africa Recombinant Insulin Glulisine Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa Recombinant Insulin Glulisine Sales Forecast by Country (2027-2032) & (k units) Table 130. Middle East and Africa Recombinant Insulin Glulisine Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Recombinant Insulin Glulisine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Recombinant Insulin Glulisine Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa Recombinant Insulin Glulisine Market Share by Country (2021-2026) Table 134. Middle East and Africa Recombinant Insulin Glulisine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa Recombinant Insulin Glulisine Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Recombinant Insulin Glulisine Distributors List Table 139. Recombinant Insulin Glulisine Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Recombinant Insulin Glulisine Image Figure 2. Global Recombinant Insulin Glulisine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Insulin Glulisine Market Size (2021-2032) & (US$ Million) Figure 4. Global Recombinant Insulin Glulisine Sales (2021-2032) & (k units) Figure 5. Vial Image Figure 6. Global Vial Sales YoY Growth (2021-2032) & (k units) Figure 7. Pre-filled Image Figure 8. Global Pre-filled Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Recombinant Insulin Glulisine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Recombinant Insulin Glulisine Market Share by Type 2025 VS 2032 Figure 11. North America Recombinant Insulin Glulisine Sales Market Share in Volume by Type in 2025 Figure 12. North America Recombinant Insulin Glulisine Sales Market Share in Value by Type in 2025 Figure 13. Europe Recombinant Insulin Glulisine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Recombinant Insulin Glulisine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Recombinant Insulin Glulisine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Recombinant Insulin Glulisine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Recombinant Insulin Glulisine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Recombinant Insulin Glulisine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Recombinant Insulin Glulisine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Recombinant Insulin Glulisine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Recombinant Insulin Glulisine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Type 1 Diabetes Image Figure 24. Global Type 1 Diabetes Sales YoY Growth (2021-2032) & (k units) Figure 25. Type 2 Diabetes Image Figure 26. Global Type 2 Diabetes Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Recombinant Insulin Glulisine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Recombinant Insulin Glulisine Market Share by Application 2025 VS 2032 Figure 29. North America Recombinant Insulin Glulisine Sales Market Share in Volume by Application in 2025 Figure 30. North America Recombinant Insulin Glulisine Sales Market Share in Value by Application in 2025 Figure 31. Europe Recombinant Insulin Glulisine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Recombinant Insulin Glulisine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Recombinant Insulin Glulisine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Recombinant Insulin Glulisine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Recombinant Insulin Glulisine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Recombinant Insulin Glulisine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Recombinant Insulin Glulisine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Recombinant Insulin Glulisine Sales Market Share in Value by Application in 2025 Figure 39. North America Recombinant Insulin Glulisine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Recombinant Insulin Glulisine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Recombinant Insulin Glulisine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Recombinant Insulin Glulisine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Recombinant Insulin Glulisine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Recombinant Insulin Glulisine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Recombinant Insulin Glulisine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Recombinant Insulin Glulisine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Recombinant Insulin Glulisine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Recombinant Insulin Glulisine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Recombinant Insulin Glulisine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Recombinant Insulin Glulisine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Recombinant Insulin Glulisine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Recombinant Insulin Glulisine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Recombinant Insulin Glulisine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Recombinant Insulin Glulisine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Recombinant Insulin Glulisine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Recombinant Insulin Glulisine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Recombinant Insulin Glulisine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Recombinant Insulin Glulisine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Recombinant Insulin Glulisine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Recombinant Insulin Glulisine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Vial
  • Pre-filled
Applications
  • Type 1 Diabetes
  • Type 2 Diabetes
Companies covered
  • Sanofi
  • KALBE PHARMA
  • Amicus

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Recombinant Insulin Glulisine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Recombinant Insulin Glulisine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Recombinant Insulin Glulisine Market by Type
  6. 1.3.1 Vial
  7. 1.3.2 Pre-filled
  8. 1.4 Global Recombinant Insulin Glulisine Market Size by Type
  9. 1.4.1 Global Recombinant Insulin Glulisine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Recombinant Insulin Glulisine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Recombinant Insulin Glulisine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Recombinant Insulin Glulisine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Recombinant Insulin Glulisine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Recombinant Insulin Glulisine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Recombinant Insulin Glulisine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Recombinant Insulin Glulisine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Recombinant Insulin Glulisine Industry Trends
  2. 2.2 Recombinant Insulin Glulisine Industry Drivers
  3. 2.3 Recombinant Insulin Glulisine Industry Opportunities and Challenges
  4. 2.4 Recombinant Insulin Glulisine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Recombinant Insulin Glulisine Revenue (2021-2026)
  2. 3.2 Global Top Players by Recombinant Insulin Glulisine Sales (2021-2026)
  3. 3.3 Global Top Players by Recombinant Insulin Glulisine Price (2021-2026)
  4. 3.4 Global Recombinant Insulin Glulisine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Recombinant Insulin Glulisine Major Company Production Sites & Headquarters
  6. 3.6 Global Recombinant Insulin Glulisine Company, Product Type & Application
  7. 3.7 Global Recombinant Insulin Glulisine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Recombinant Insulin Glulisine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Recombinant Insulin Glulisine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Recombinant Insulin Glulisine Tier 1, Tier 2, and Tier 3
4 Recombinant Insulin Glulisine Regional Status and Outlook
  1. 4.1 Global Recombinant Insulin Glulisine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Recombinant Insulin Glulisine Historic Market Size by Region
  3. 4.2.1 Global Recombinant Insulin Glulisine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Recombinant Insulin Glulisine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Recombinant Insulin Glulisine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Recombinant Insulin Glulisine Forecasted Market Size by Region
  7. 4.3.1 Global Recombinant Insulin Glulisine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Recombinant Insulin Glulisine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Recombinant Insulin Glulisine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Recombinant Insulin Glulisine by Application
  1. 5.1 Recombinant Insulin Glulisine Market by Application
  2. 5.1.1 Type 1 Diabetes
  3. 5.1.2 Type 2 Diabetes
  4. 5.2 Global Recombinant Insulin Glulisine Market Size by Application
  5. 5.2.1 Global Recombinant Insulin Glulisine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Recombinant Insulin Glulisine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Recombinant Insulin Glulisine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Recombinant Insulin Glulisine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Recombinant Insulin Glulisine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Recombinant Insulin Glulisine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Recombinant Insulin Glulisine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Recombinant Insulin Glulisine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Recombinant Insulin Glulisine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Recombinant Insulin Glulisine Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 KALBE PHARMA
  8. 6.2.1 KALBE PHARMA Company Information
  9. 6.2.2 KALBE PHARMA Business Overview
  10. 6.2.3 KALBE PHARMA Recombinant Insulin Glulisine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 KALBE PHARMA Recombinant Insulin Glulisine Product Portfolio
  12. 6.2.5 KALBE PHARMA Recent Developments
  13. 6.3 Amicus
  14. 6.3.1 Amicus Company Information
  15. 6.3.2 Amicus Business Overview
  16. 6.3.3 Amicus Recombinant Insulin Glulisine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Amicus Recombinant Insulin Glulisine Product Portfolio
  18. 6.3.5 Amicus Recent Developments
7 North America by Country
  1. 7.1 North America Recombinant Insulin Glulisine Sales by Country
  2. 7.1.1 North America Recombinant Insulin Glulisine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Recombinant Insulin Glulisine Sales by Country (2021-2026)
  4. 7.1.3 North America Recombinant Insulin Glulisine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Recombinant Insulin Glulisine Market Size by Country
  6. 7.2.1 North America Recombinant Insulin Glulisine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Recombinant Insulin Glulisine Market Size by Country (2021-2026)
  8. 7.2.3 North America Recombinant Insulin Glulisine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Recombinant Insulin Glulisine Sales by Country
  2. 8.1.1 Europe Recombinant Insulin Glulisine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Recombinant Insulin Glulisine Sales by Country (2021-2026)
  4. 8.1.3 Europe Recombinant Insulin Glulisine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Recombinant Insulin Glulisine Market Size by Country
  6. 8.2.1 Europe Recombinant Insulin Glulisine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Recombinant Insulin Glulisine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Recombinant Insulin Glulisine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Recombinant Insulin Glulisine Sales by Country
  2. 9.1.1 Asia-Pacific Recombinant Insulin Glulisine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Recombinant Insulin Glulisine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Recombinant Insulin Glulisine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Recombinant Insulin Glulisine Market Size by Country
  6. 9.2.1 Asia-Pacific Recombinant Insulin Glulisine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Recombinant Insulin Glulisine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Recombinant Insulin Glulisine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Recombinant Insulin Glulisine Sales by Country
  2. 10.1.1 South America Recombinant Insulin Glulisine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Recombinant Insulin Glulisine Sales by Country (2021-2026)
  4. 10.1.3 South America Recombinant Insulin Glulisine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Recombinant Insulin Glulisine Market Size by Country
  6. 10.2.1 South America Recombinant Insulin Glulisine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Recombinant Insulin Glulisine Market Size by Country (2021-2026)
  8. 10.2.3 South America Recombinant Insulin Glulisine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Recombinant Insulin Glulisine Sales by Country
  2. 11.1.1 Middle East and Africa Recombinant Insulin Glulisine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Recombinant Insulin Glulisine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Recombinant Insulin Glulisine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Recombinant Insulin Glulisine Market Size by Country
  6. 11.2.1 Middle East and Africa Recombinant Insulin Glulisine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Recombinant Insulin Glulisine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Recombinant Insulin Glulisine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Recombinant Insulin Glulisine Value Chain Analysis
  2. 12.1.1 Recombinant Insulin Glulisine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Recombinant Insulin Glulisine Production Mode & Process
  7. 12.2 Recombinant Insulin Glulisine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Recombinant Insulin Glulisine Distributors
  10. 12.2.3 Recombinant Insulin Glulisine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst